-
Mashup Score: 2Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group - 27 day(s) ago
Patients with cancer can be immunocompromised because of their disease and/or due to anticancer therapy. In this population, severe influenza virus infections are associated with an elevated risk of morbidity and mortality. Influenza vaccination is therefore highly recommended in cancer patients, including those receiving anticancer therapy. However, vaccination coverage remains far below the recommended target for vulnerable subjects. Six specialists in oncology, hematology, immunology, and public health/vaccinology convened with the objective of developing strategies, based on evidence and clinical experience, for improving influenza vaccination coverage in cancer patients. This viewpoint provides an overview of current influenza vaccination recommendations in cancer patients, discusses barriers to vaccination coverage, and presents strategies for overcoming said barriers. New immunization issues raised by the COVID-19 pandemic are also addressed. Future directions include improving
Source: www.mdpi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center - 27 day(s) ago
Journal of Cancer Education – Influenza morbidity and mortality can be severe and costly. Vaccination rates remain suboptimal in cancer patients due to provider- and patient-related factors. The…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group [Apr 16, 2024] @paolo_bonanni et al. Vaccines https://t.co/l7XbvG5D8l #Flu #IDonc https://t.co/sD3EQnOb5b